pyridostigmine bromide has been researched along with Disease Exacerbation in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| de Meel, RHP; Tannemaat, MR; Verschuuren, JJGM | 1 |
| Deroma, M; Giannini, A; Logoteta, A; Monti, M; Piccioni, MG; Tabacco, S | 1 |
| Govindarajan, R; Singh, S | 1 |
| Abid, F; Fisher, KS; Gill, J; Lopez, MA; Lotze, T; Shah, VS; Todd, HF; Yang, MB | 1 |
| Agba, AI; Apetse, K; Ayena, KD; Balo, KP; Balogou, KA; Diatewa, BM; Domingo, SA; Maneh, N | 1 |
| Lowwongngam, K; Padungkiatsagul, T; Poonyathalang, A; Vanikieti, K; Visudtibhan, A | 1 |
| Bopeththa, BVKM; Hewapathirana, HLI; Hewavithana, PB; Ralapanawa, U | 1 |
| Abicht, A; Bestué, M; Camacho, A; Colomer, J; Dusl, M; Evangelista, T; García-Hoyos, M; García-Ribes, A; Jiménez, E; Lochmüller, H; Nascimento, A; Natera-de Benito, D; Ortez, C; Töpf, A; Trujillo-Tiebas, MJ; Vilchez, JJ | 1 |
| Chen, Z; Lei, Y; Liu, W; Lun, X; Luo, H; Su, C; Yang, W; Zhong, B; Zhu, H; Zou, J | 1 |
| Barenboim, E; Blum, S; Gadoth, N; Karmon, Y; Levite, R | 1 |
| Auff, E; Cetin, H; Hilger, E; Jung, R; Paul, A; Wuschitz, B; Zach, H; Zimprich, F | 1 |
| Angeletti, CA; Lucchi, M; Mussi, A; Ricciardi, R | 1 |
| Kupersmith, MJ | 1 |
| Goldstein, JM; Knorr, AM; Lesser, RL; Monsul, NT; Patwa, HS | 1 |
| Claussen, GC; Hatanaka, Y; Hemmi, S; Morgan, MB; Oh, SJ; Scheufele, ML; Wolfe, GI | 1 |
| Bershad, EM; Feen, ES; Suarez, JI | 1 |
| Buncic, JR; Mullaney, P; Smith, R; Vajsar, J | 1 |
2 review(s) available for pyridostigmine bromide and Disease Exacerbation
| Article | Year |
|---|---|
Myasthaenia gravis in pregnancy, delivery and newborn.
Topics: Adrenal Cortex Hormones; Arthrogryposis; Breast Feeding; Cholinesterase Inhibitors; Cleft Palate; Congenital Abnormalities; Delivery, Obstetric; Disease Progression; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Myasthenia Gravis; Patient Care Team; Perinatal Mortality; Polyhydramnios; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pyridostigmine Bromide; Recurrence | 2020 |
Myasthenia gravis crisis.
Topics: Blood Gas Analysis; Cholinesterase Inhibitors; Diagnosis, Differential; Disease Progression; Humans; Immunoglobulins, Intravenous; Muscle, Skeletal; Myasthenia Gravis; Plasma Exchange; Pyridostigmine Bromide; Receptors, Cholinergic; Respiration, Artificial; Respiratory Insufficiency; Risk Factors | 2008 |
15 other study(ies) available for pyridostigmine bromide and Disease Exacerbation
| Article | Year |
|---|---|
Heterogeneity and shifts in distribution of muscle weakness in myasthenia gravis.
Topics: Adult; Age of Onset; Aged; Blepharoptosis; Cholinesterase Inhibitors; Cohort Studies; Deglutition Disorders; Diplopia; Disease Progression; Dysarthria; Extremities; Facial Muscles; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mastication; Masticatory Muscles; Middle Aged; Muscle Weakness; Muscle, Skeletal; Myasthenia Gravis; Neck Muscles; Oculomotor Muscles; Pharyngeal Muscles; Phenotype; Prednisone; Prospective Studies; Pyridostigmine Bromide; Respiratory Muscles | 2019 |
COVID-19 and generalized Myasthenia Gravis exacerbation: A case report.
Topics: Adult; Betacoronavirus; Cholinesterase Inhibitors; Coronavirus Infections; COVID-19; Disease Progression; Female; Glucocorticoids; Humans; Hypercapnia; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Myasthenia Gravis; Mycophenolic Acid; Pandemics; Plasma Exchange; Pneumonia, Viral; Prednisone; Pyridostigmine Bromide; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Thymectomy; Tomography, X-Ray Computed | 2020 |
Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cholinesterase Inhibitors; Disease Progression; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Male; Myasthenia Gravis; Prednisone; Pyridostigmine Bromide; Retrospective Studies; Treatment Outcome | 2021 |
[Juvenile myasthenia gravis in sub-Saharan Africa: a case study of two consanguine sisters born from consanguinity in Togo].
Topics: Age of Onset; Child; Consanguinity; Disease Progression; Female; Humans; Lost to Follow-Up; Myasthenia Gravis; Oculomotor Nerve Diseases; Pyridostigmine Bromide; Refractive Errors; Togo; Visual Acuity | 2017 |
Juvenile Ocular Myasthenia Gravis: Presentation and Outcome of a Large Cohort.
Topics: Adolescent; Blepharoptosis; Child; Child, Preschool; Cholinesterase Inhibitors; Disease Progression; Female; Follow-Up Studies; Humans; Male; Myasthenia Gravis; Ophthalmoplegia; Outcome Assessment, Health Care; Pyridostigmine Bromide; Retrospective Studies | 2018 |
Myasthenic crisis following iodinated contrast material (iohexol) aspiration: a case report.
Topics: Cholinesterase Inhibitors; Contrast Media; Deglutition Disorders; Disease Progression; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Iohexol; Male; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Pneumonia, Aspiration; Pneumothorax; Prednisolone; Pyridostigmine Bromide; Respiration, Artificial; Respiratory Aspiration; Respiratory Insufficiency | 2019 |
Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations.
Topics: 4-Aminopyridine; Adolescent; Adult; Amifampridine; Child; Child, Preschool; Cholinesterase Inhibitors; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscle Proteins; Mutation; Myasthenic Syndromes, Congenital; Phenotype; Potassium Channel Blockers; Pyridostigmine Bromide; Young Adult | 2016 |
Preoperative Anxiety in Patients With Myasthenia Gravis and Risk for Myasthenic Crisis After Extended Transsternal Thymectomy: A CONSORT Study.
Topics: Adolescent; Adult; Anxiety; China; Cholinesterase Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Pneumonia; Postoperative Complications; Pyridostigmine Bromide; Retrospective Studies; Risk Assessment; Risk Factors; Thymectomy; Thymoma | 2016 |
Myasthenia gravis and return to flying status.
Topics: Adult; Aerospace Medicine; Cholinesterase Inhibitors; Disease Progression; Glucocorticoids; Health Status; Humans; Israel; Male; Middle Aged; Military Personnel; Myasthenia Gravis; Prednisone; Prognosis; Pyridostigmine Bromide; Receptors, Cholinergic; Severity of Illness Index; Treatment Failure | 2010 |
The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis.
Topics: Adult; Age of Onset; Aged; Anti-Inflammatory Agents; Autoantibodies; Blepharoptosis; Cholinesterase Inhibitors; Disease Progression; Eye Diseases; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscle Weakness; Myasthenia Gravis; Oculomotor Muscles; Prednisolone; Pyridostigmine Bromide; Receptors, Cholinergic; Retrospective Studies; Risk Assessment | 2013 |
Thymectomy in ocular myasthenia gravis.
Topics: Cholinesterase Inhibitors; Disease Progression; Drug Resistance; Eye Diseases; Humans; Myasthenia Gravis; Patient Selection; Predictive Value of Tests; Pyridostigmine Bromide; Remission Induction; Thymectomy; Treatment Outcome | 2003 |
Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized disease?
Topics: Disease Progression; Drug Administration Schedule; Humans; Immunosuppressive Agents; Myasthenia Gravis; Prednisone; Pyridostigmine Bromide; Receptors, Cholinergic | 2004 |
The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
Topics: Cholinesterase Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Oculomotor Muscles; Prednisone; Pyridostigmine Bromide; Receptors, Cholinergic; Retrospective Studies; Treatment Outcome | 2004 |
Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG.
Topics: Adult; Autoantibodies; Causality; Cholinesterase Inhibitors; Disease Progression; Drug Resistance; Edrophonium; Female; Humans; Male; Myasthenia Gravis; Patient Selection; Predictive Value of Tests; Pyridostigmine Bromide; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic | 2005 |
The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
Topics: Adolescent; Blepharoptosis; Child; Child, Preschool; Cholinesterase Inhibitors; Disease Progression; Female; Glucocorticoids; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Male; Myasthenia Gravis; Myasthenia Gravis, Neonatal; Myasthenic Syndromes, Congenital; Ontario; Ophthalmoplegia; Prednisone; Pyridostigmine Bromide; Retrospective Studies; Strabismus | 2000 |